New Oral Anticoagulants: Factor IIa and Xa Inhibitors
In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the new oral anticoagulation agents.
Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy
This activity is not accredited for technicians
At the conclusion of the activity, pharmacists will be able to:
1. Discuss the mechanism of action, indications, contraindication and adverse effects
2. Discuss the available monitoring and reversibility of these agents
3. Identify patients that may benefit from the new agents and those that may not
Michael Smith, RPh, PharmD, BCPS, CACP
East Region Clinical Manager, Pharmacy
William W Backus Hospital
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Click on the registration link to register for this activity. The cost is $15.00 if registering separately or 13 activities for $120.00 if bundling. See registration site for details.
This activity has been supported by an educational grant from CSL Behring
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-15-075-H01-P). All credits will be electronically submitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: May 15, 2016
Planned expiration date: May 15, 2019
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.